DAWN LITTLE: Open Payments
NPI 1578221636 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,368 in 60 payments from 36 companies in 2025. Trend: 2023 $312 · 2024 $424 · 2025 $1,368
Food & beverage: $1,368
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| PFIZER INC. | 7 | $109 |
| Novo Nordisk Inc | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| ABBVIE INC. | 3 | $66 |
| Daiichi Sankyo Inc. | 2 | $55 |
| ARRAY BIOPHARMA INC | 2 | $54 |
| Celgene Corporation | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Stemline Therapeutics Inc. | 1 | $34 |
Products named: KISQALI, DATROWAY, CALQUENCE, IMBRUVICA, REBLOZYL, ENHERTU, NURTEC ODT, Ozempic.
Industry payments across IN — which companies pay providers there.
